Tom Gevers

1.1k citations

13 papers · 847 indexed · h-index 12

Impact in

Infectious Diseases top 2%
- Tuberculosis Research and Epidemiology
Epidemiology top 5%
- Mycobacterium research and diagnosis
- Respiratory viral infections research
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumonia and Respiratory Infections

Papers in ⓘ

Molecular Medicine 3
- Antibiotic Resistance in Bacteria 3
Infectious Diseases 8
- Tuberculosis Research and Epidemiology 7

Co-authors: Koen Andries (12 shared papers)Nacer Lounis (7 shared papers)Luc Vranckx (3 shared papers)Anil Koul (2 shared papers)Nele Coeck (1 shared paper)Bouke C. de Jong (1 shared paper)Kim Thys (1 shared paper)Cristina Villellas (1 shared paper)
Journals: Antimicrobial Agents and Chemotherapy (5 papers)Antiviral Research (2 papers)Journal of Medicinal Chemistry (2 papers)Journal of Clinical Microbiology (1 paper)Proceedings of the National Academy of Sciences (1 paper)
Partner nations: United States Belgium France

In The Last Decade

Tom Gevers

13 papers receiving 815 citations

Peers

Countries citing papers authored by Tom Gevers

Since Specialization

Citations

This map shows the geographic impact of Tom Gevers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Gevers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Gevers more than expected).

Fields of papers citing papers by Tom Gevers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Gevers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Gevers. The network helps show where Tom Gevers may publish in the future.

Co-authors

The 25 scholars most cited alongside Tom Gevers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tom Gevers Line = papers co-authored together Tom Gevers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline PLoS ONE ·Koen Andries, Cristina Villellas, Nele Coeck, Kim Thys, Tom Gevers, Luc Vranckx, Nacer Lounis, Bouke C. de Jong, Anil Koul	2014	288
2	Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus Antiviral Research ·Koen Andries, Marc Moeremans, Tom Gevers, Rudy Willebrords, Cois Sommen, Jean Lacrampe, Frans Janssens, Philip R. Wyde	2003	91
3	Pharmacokinetics and Pharmacodynamics of TMC207 and Its N -Desmethyl Metabolite in a Murine Model of Tuberculosis Antimicrobial Agents and Chemotherapy ·M.C. Rouan, Nacer Lounis, Tom Gevers, Lieve Dillen, Ron Gilissen, Araz Raoof, Koen Andries	2011	91
4	Selection of a Respiratory Syncytial Virus Fusion Inhibitor Clinical Candidate. 2. Discovery of a Morpholinopropylaminobenzimidazole Derivative (TMC353121) Journal of Medicinal Chemistry ·Jean‐François Bonfanti, Christophe Meyer, Frédéric Doublet, Jérôme Fortin, Philippe Müller, Laurence Quéguiner, Tom Gevers, Peggy Janssens, Heidi Szel, Rudy Willebrords, Philip Timmerman, Koen Wuyts, P. Van Remoortere, Frans Janssens, Piet Wigerinck, Koen Andries	2008	76
5	Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein Proceedings of the National Academy of Sciences ·Dirk Roymans, Hendrik L. De Bondt, Éric Arnoult, Peggy Geluykens, Tom Gevers, Marcia Van Ginderen, Nick Verheyen, Hidong Kim, Rudy Willebrords, Jean‐François Bonfanti, Wouter Bruinzeel, Maxwell D. Cummings, Herman van Vlijmen, Koen Andries	2009	66
6	Impact of the Interaction of R207910 with Rifampin on the Treatment of Tuberculosis Studied in the Mouse Model Antimicrobial Agents and Chemotherapy ·Nacer Lounis, Tom Gevers, Joke Van Den Berg, Koen Andries	2008	50
7	Bactericidal Potencies of New Regimens Are Not Predictive of Their Sterilizing Potencies in a Murine Model of Tuberculosis Antimicrobial Agents and Chemotherapy ·Koen Andries, Tom Gevers, Nacer Lounis	2010	43
8	ATP Synthase Inhibition of Mycobacterium avium Is Not Bactericidal Antimicrobial Agents and Chemotherapy ·Nacer Lounis, Tom Gevers, Joke Van Den Berg, Luc Vranckx, Koen Andries	2009	40
9	Selection of a Respiratory Syncytial Virus Fusion Inhibitor Clinical Candidate, Part 1: Improving the Pharmacokinetic Profile Using the Structure−Property Relationship Journal of Medicinal Chemistry ·Jean‐François Bonfanti, Frédéric Doublet, Jérôme Fortin, Jean Lacrampe, Jérôme Guillemont, Philippe Müller, Laurence Quéguiner, Éric Arnoult, Tom Gevers, Peggy Janssens, Heidi Szel, Rudy Willebrords, Philip Timmerman, Koen Wuyts, Frans Janssens, Cois Sommen, Piet Wigerinck, Koen Andries	2007	37
10	Prevention of Drug Carryover Effects in Studies Assessing Antimycobacterial Efficacy of TMC207 Journal of Clinical Microbiology ·Nacer Lounis, Tom Gevers, Joke Van Den Berg, Tom Verhaeghe, Rolf van Heeswijk, Koen Andries	2008	30
11	In vitro culture conditions affecting minimal inhibitory concentration of bedaquiline against M. tuberculosis Médecine et Maladies Infectieuses ·Nacer Lounis, Luc Vranckx, Tom Gevers, Koné Kaniga, Koen Andries	2016	17
12	Pharmacokinetics-Pharmacodynamics of a Respiratory Syncytial Virus Fusion Inhibitor in the Cotton Rat Model Antimicrobial Agents and Chemotherapy ·M.C. Rouan, Tom Gevers, Dirk Roymans, Loeckie De Zwart, David Nauwelaers, Marc De Meulder, P. Van Remoortere, Marc Vanstockem, Anil Koul, Kenny Simmen, Koen Andries	2010	17
13	R170591, a New Antiviral with picoMolar Activity against Respiratory Syncytial Virus. Antiviral Research ·K Andries, M. Moeremans, Tom Gevers, Rudy Willebrords, S Sommen, Jean Lacrampe, Frans Janssens	2001	1

About Tom Gevers

Tom Gevers is a scholar working on Molecular Medicine, Infectious Diseases, Epidemiology, Pharmacology and Oncology, having authored 13 papers that have together received 847 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (7 papers), Respiratory viral infections research (6 papers), Mycobacterium research and diagnosis (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Antibiotic Resistance in Bacteria (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Pneumonia and Respiratory Infections (2 papers) and Diagnosis and treatment of tuberculosis (2 papers). The work is most often cited by research in Infectious Diseases (611 citations), Epidemiology (624 citations), Molecular Medicine (84 citations), Organic Chemistry (102 citations) and Virology (16 citations). Tom Gevers has collaborated with scholars based in United States, Belgium and France. Frequent co-authors include Koen Andries, Nacer Lounis, Luc Vranckx, Anil Koul, Nele Coeck, Bouke C. de Jong, Kim Thys, Cristina Villellas, Rudy Willebrords and Frans Janssens. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Antiviral Research, Journal of Medicinal Chemistry, Journal of Clinical Microbiology and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact